Ronald M. Kurtz MD - 11 Jul 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
President & CEO, Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
11 Jul 2024
Net transactions value
+$203,604
Form type
4
Filing time
12 Jul 2024, 19:12:01 UTC
Previous filing
06 May 2024
Next filing
09 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $203,604 +13,500 +34% $15.08 53,500 11 Jul 2024 Direct
holding RXST Common Stock 764,610 11 Jul 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -13,500 -33% $0.000000 26,836 11 Jul 2024 Common Stock 13,500 $15.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
F2 Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the "2015 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2015 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. The option originally covered 500,000 shares of common stock pre 10.33 for 1 reverse split shares.

Remarks:

Exhibit 24 - Power of Attorney